An FDA advisory panel on Bristol Myers Squibb Opdivo and Merck Keytruda will examine if PD-L1 tumor expression should limit ...

Shares of Bristol Myers Squibb Co. BMY rallied 1.86% to $50.94 Tuesday, on what proved to be an all-around favorable trading ...

US poised to approve KarXT as new antipsychotic treatment for disorder, which could offer reduced side-effects ...

Delayed diagnosis and treatment of CCCA result in insufficiently aggressive therapy and risks an avoidable consequence, ...

Several studies revealed high cardiovascular risk in people with type 1 diabetes, including in those who are asymptomatic and ...

Besides stomach cancer, the FDA also raised a similar concern for PD-1 drugs in first-line esophageal squamous cell carcinoma ...

There was a lot to cheer outside Enterprise Center Tuesday morning. Riders ready to brave their bikes with the St. Louis ...

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) shares are trading lower by 4.11% to $15.62 during Tuesday’s session after the ...

Laura Foran's late husband, Gerry, had a desk plaque that said, "I'm kind of a big deal." The 47-year-old Allentown woman is ...

"If patients with low or no PD-L1 expression are not expected to benefit based on the available data, then administering anti ...

TENS of thousands of Brits are estimated to be unknowingly living with the silent heart condition that nearly killed ...